TherapeuticsMD, Inc. (TXMD) Shareholders’ equity 2016–2025
TherapeuticsMD, Inc. (TXMD) shareholders’ equity at each fiscal year-end, per SEC filings.
$26.9MFY2025 · since FY2016: $127.5M → $26.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $26.9M | -1.8% |
| FY2024 | $27.4M | -6.5% |
| FY2023 | $29.3M | -16.7% |
| FY2022 | $35.1M | +137.5% |
| FY2021 | -$93.6M | +24.5% |
| FY2020 | -$124.0M | -1447.7% |
| FY2019 | $9.2M | -90.6% |
| FY2018 | $97.5M | -24.9% |
| FY2017 | $129.9M | +1.9% |
| FY2016 | $127.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice